About Accelerator Fund
Accelerator Fund is a venture capital firm located in Pittsburgh, United States. As of Mar 2017, Accelerator Fund has invested in 10 companies. It primarily invests in Series A round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to Enterprise Applications and High Tech. Most recently it participated in the $***** Series C round of ALung Overall, Accelerator Fund portfolio has seen 1 IPO and 1 acquisition, namely Cognition Therapeutics and ALung. A lot of funds co-invest with Accelerator Fund, with names like UPMC sharing a substantial percentage of its portfolio.Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series C & 2 more
Portfolio IPOs
Portfolio Acquisitions
Accelerator Fund's List of Top Investments
Accelerator Fund has a portfolio of 10 companies. Their most notable investmentis in KabongoTheir portfolio spans across United States and United Kingdom. They have invested in Life Sciences, Enterprise Applications, High Tech and 8 other sectors, across stages such as Series A, Series C and 2 more. Here is the list of top investments by Accelerator Fund:Developer of small molecule drugs for neurodegenerative diseases. The company uses a proprietary screening technique to identify molecules capable of blocking toxic oligomeric proteins that cause the disease. It develops a pipeline for Alzheimer's, dementia, and Synucleinopathies.
Key facts about Cognition Therapeutics
- Founded Year: 2007
- Location: Pittsburgh (United States)
- Stage: Public
- Total Funding till date: $36.1M
- Employee Count: 31 as on May 31, 2026
- Investors: iNetworks, Bios Partners and 28 Others
- Latest Funding Round: Grant (prize money), Sep 27, 2022, $*****
- Highlight: Public
2. ALung
Developer of extracorporeal CO2 removal system to supplement mechanical ventilation. TheHemolung Cartridge couples a centrifugal blood pump and gas exchange membrane into one device.
Key facts about ALung
- Founded Year: 1997
- Location: Pittsburgh (United States)
- Stage: Acquired
- Total Funding till date: $150M
- Employee Count: 3,536 as on May 31, 2026
- Investors: UPMC, West Capital Advisors and 14 Others
- Latest Funding Round: Series C, May 06, 2021, $*****
- Highlight: Acquired
3. Medrobotics
Medrobotics' Flex Retractor offers a highly articulated multi-linked endoscope that enables minimally-invasive procedures most types of surgery. Their platform includes on-board visualization and can accept a variety of third party surgical instruments. The system enables physicians to operate through non-linear circuitous paths, self-supported, and through a single access point. Their device has received approval in Europe and has cleared FDA requirements with only final approval pending.
Key facts about Medrobotics
- Founded Year: 2005
- Location: Raynham (United States)
- Stage: Deadpooled
- Total Funding till date: $193M
- Employee Count: 115 as on Dec 31, 2018
- Investors: Hercules Capital, Accelerator Fund and 4 Others
- Latest Funding Round: Series H, Jan 26, 2017, $*****
Developer of surgical adhesives and sealants. Its lead product TissuGlu Surgical Adhesive received FDA approval in Feb 2015. Another product Sylys Surgical Sealant has received the CE Mark in Aug 2015.
Key facts about Cohera Medical
- Founded Year: 2006
- Location: Pittsburgh (United States)
- Stage: Deadpooled
- Total Funding till date: $136M
- Investors: Accelerator Fund, H.I.G. Private Equity and 5 Others
- Latest Funding Round: Series E, Oct 26, 2015, $*****
Key facts about Moonstone Nutrition
- Founded Year: 2019
- Location: Pittsburgh (United States)
- Annual Revenue: $1M - $10M as on Dec 31, 2023
- Valuation: $*****
- Stage: Seed
- Total Funding till date: $80K
- Employee Count: 6 as on Mar 31, 2026
- Investors: Accelerator Fund and Pittsburgh Life Sciences Greenhouse
- Latest Funding Round: Seed, Mar 07, 2024, $*****
Accelerator Fund's Year-on-Year Investment Trends
Accelerator Fund has invested in 10 companies over the last 20 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in ALung and most recent follow-on round was in Cognition Therapeutics.Accelerator Fund's Investments by Stage
Accelerator Fund has made 2 investments in Series A stage with an average round size of $1.08M, 2 investments in Series C stage with an average round size of $20.3M, 1 investment in Seed stage with an average round size of $100K and 1 investment in Series B stage with an average round size of $3.02M.Stage of entry | No. of Investments |
|---|---|
Series A | 2 |
Series C | 2 |
Seed | 1 |
Series B | 1 |
Note: We have considered here, only first round of investments
Accelerator Fund's Investments by Sector
Accelerator Fund has a diverse portfolio, with companies operating in the Life Sciences, EdTech and Sustainability Tech. Notably, it has invested in 9 Tech companies, 6 Enterprise (B2B) companies, 4 Tech hardware companies and at least 3 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Life Sciences | 5 |
EdTech | 1 |
Sustainability Tech | 1 |
Note: We have considered here, only first round of investments
Accelerator Fund's Investments by Geography
Accelerator Fund has made most investments in United States (6).Accelerator Fund's recent investments
Accelerator Fund has not made any investment in 2026 so far.Here are the most recent investments by Accelerator Fund:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Mar 2017 | United States | Series C | 3277 | [+5] | |
Jul 22, 2015 | United States | Series B | 9731 | [+7] | |
Dec 18, 2014 | United States | Series C | 9395 | ||
Jan 21, 2014 | United States | Series D | 1894 | - | |
Sep 05, 2013 | United States | Series B | 3347 |
IPOs and Publicly Listed companies in Accelerator Fund's Portfolio
1 of Accelerator Fund's portfolio company became public - Cognition Therapeutics. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Oct 2021 at marketcap of $256MHere are Accelerator Fund's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 08, 2021 | Sep 05, 2013 | Series B | 8178 |
Acquired companies in Accelerator Fund's Portfolio
1 company from Accelerator Fund's portfolio has been acquired. The most recent acquisition was ALung in May 2022 by LivaNova for $*****.Here are Accelerator Fund's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
May 05, 2022 | Mar 2017 | Series C | 6856 |
Co-investors of Accelerator Fund
Over the past 20 years, 35 investors have co-invested in Accelerator Fund's portfolio companies. This includes only funds.
- Invested before Accelerator Fund: Pittsburgh Life Sciences Greenhouse, Golden Seeds and 11 others have invested in rounds before Accelerator Fund. There are 3 companies where Pittsburgh Life Sciences Greenhouse has invested before Accelerator Fund and 1 company where Golden Seeds has invested before Accelerator Fund.
- Top Co-investors of Accelerator Fund: 6 investors entered a company along with Accelerator Fund. These include investors like UPMC (1 company).
- Invested after Accelerator Fund: A total of 16 investors have invested in Accelerator Fund's portfolio after their investments. Top Investors include Cowtown Angels (1 company), Scale (1 company) and Dolby Family Ventures (1 company).
Recent News related to Accelerator Fund
•
Rural Tech Startup HESA raises USD 2 million Seed funding round from Venture Catalysts and 9UnicornsSmart State India•Jul 01, 2021•Hesa, 9Unicorns, Venture Catalysts, Hesa and 1 other
•
•
ALung Technologies Closes $36 Million FinancingBusiness Wire•Apr 11, 2017•ALung, UPMC, Philips, Abiomed and 6 others
•
Rinovum Women’s Health Secures $3M Series C Funding | Business WireBusiness Wire•Dec 19, 2014•Rinovum, Accelerator Fund, BlueTreeVC
•
•
•
